Eisai Inc. recently announced that results from the CAMELLIA-TIMI 61 cardiovascular (CV) outcomes trial in patients trea...
The main reasons why people die after non-cardiac surgery are revealed in a study of more than 40,000 patients from six ...
Feinstein Institute for Medical Research Professor Alex C. Spyropoulos, MD, has uncovered an anticoagulant treatment str...
The British Heart Foundation (BHF) has launched the Big Beat Challenge, a unique research funding award that will bring ...
Shire, the leading global biotechnology company focused on rare diseases, has announced that following priority review, ...
GT Biopharma Inc. (GTBP) an immuno-oncology biotechnology company focused on innovative treatments based on the company'...
Facebook has partnered with New York University (NYU) School of Medicine to initiate a research project focused on lever...
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...
Singapore- DexCom, leader in continuous glucose monitoring for people with diabetes, announced today that it has acquire...
Singapore- Bluebird Bio and Gritstone Oncology collaborates to research, develop and commercialize products for the trea...
Royal Philips, a global leader in health technology, has introduced the EPIQ CVx cardiovascular ultrasound system. Built...
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...
Singapore - Achillion Pharmaceuticals appoints Steven Zelenkofske, D.O. to the position of Executive Vice President...
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patie...
Singapore - ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly pre...
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade speci...
The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...
